Showing results (1871-1880 of 8,157) with videos related to

Sort By:
Pageof 816
Haematologica|April 4, 2024
HES6knockdown in human hematopoietic precursor cells reduces their in vivo engraftment potential and their capacity to differentiate into erythroid cells, B cells, T cells and plasmacytoid dendritic cellsTamara De Vos, Nicole Oatman, Lena Boehme, et al.
Haematologica|April 4, 2024
Prognostic relevance of tumor-infiltrating CD4+ cells and total metabolic tumor volume-based risk stratification in diffuse large B-cell lymphomaDaisuke Ikeda, Mitsuaki Oura, Atsushi Uehara, et al.
Haematologica|March 7, 2024
Functional and multi-omics signatures of mitapivat efficacy upon activation of pyruvate kinase in red blood cells from patients with sickle cell diseaseAngelo D'Alessandro, Kang Le, Maureen Lundt, et al.
Haematologica|March 1, 2024
Hemostasis and endothelial functionality: the double face of coagulation factorsCristina Olgasi, Simone Assanelli, Alessia Cucci, et al.
Haematologica|February 22, 2024
A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie CellulaireDéborah Meyran, Chloé Arfeuille, Sylvie Chevret, et al.
Haematologica|February 22, 2024
Targeting TNF/IL-17/MAPK pathway in hE2A-PBX1 leukemia: effects of OUL35, KJ-Pyr-9, and CID44216842Haiping Luo, Qiqi Li, Jiaxin Hong, et al.
Haematologica|February 15, 2024
Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma: results of the phase II, nonrandomized, multicenter GEM-SELIBORDARA studyVerónica González-Calle, Paula Rodríguez-Otero, Anna Sureda, et al.
Haematologica|February 15, 2024
Efanesoctocog alfa: the renaissance of Factor VIII replacement therapyYesim Dargaud, Alexandre Leuci, Alejandra Reyes Ruiz, et al.
Haematologica|November 9, 2023
Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphomaStien De Coninck, Renate De Smedt, Beatrice Lintermans, et al.
Haematologica|October 19, 2023
Multiplex immunohistochemistry elucidates increased distance between cytotoxic T cells and plasma cells in relapsed myeloma, and identifies Lag-3 as the most common checkpoint receptor on cytotoxic T cells of myeloma patientsSlavisa Ninkovic, Louise E Purton, Simon J Harrison, et al.
Pageof 816